ArticleCancer medicine2023

Anti-CLL1-based CAR T-cells with 4-1-BB or CD28/CD27 stimulatory domains in treating childhood refractory/relapsed acute myeloid leukemia.

Kunlin Pei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.